Laboratorio Farmaceutico Erfo S.p.A. (BIT:ERFO)

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Network	7.86M	4.62M	4.74M	3.95M	4.13M
Network Growth	70.12%	-2.54%	20.14%	-4.49%	-
Direct	1.09M	850.02K	702.56K	500.21K	598.35K
Direct Growth	28.04%	20.99%	40.45%	-16.40%	-
Medical	410.61K	305.89K	243.75K	124.62K	54.47K
Medical Growth	34.23%	25.49%	95.59%	128.80%	-
Other	672.22K	561.61K	576.46K	457.09K	344.23K
Other Growth	19.70%	-2.58%	26.12%	32.79%	-
Total	10.03M	6.34M	6.26M	5.03M	5.13M
Total Growth	58.28%	1.19%	24.57%	-1.96%	-

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
ITALY	8.96M	5.33M	5.24M	5.01M	5.12M
ITALY Growth	68.11%	1.61%	4.62%	-2.11%	-
Spain	-	184.00	5.17K	15.40K	8.00K
Spain Growth	-	-96.44%	-66.44%	92.63%	-
France	897.88K	852.05K	780.99K	-	-
France Growth	5.38%	9.10%	-	-	-
Belgium	175.85K	157.25K	233.48K	-	-
Belgium Growth	11.83%	-32.65%	-	-	-
Total	10.03M	6.34M	6.26M	5.03M	5.13M
Total Growth	58.28%	1.19%	24.57%	-1.96%	-

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 8, 2026

Data Sources Report a data error